AVE 0.00% 0.2¢ avecho biotechnology limited

financials have been released, page-29

  1. 34,916 Posts.
    lightbulb Created with Sketch. 480
    Cellucreme was going to be an instant company maker - a $3billion market according to POH, and provide sufficient funding for OXY trials.

    Seriously believed that? Said all along, with any new product commercialisation, it takes a good 12 months to start reaping the rewards. Cellucreme was never going to fund OXY trials. I don't ever remember POH making this claim.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.